Evidence map›Paper›PMID 32298228›Full record

ArticleEmerging infectious diseases2020

Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.

Claire Duployez, Rémi Le Guern, Claire Tinez, Anne-Laure Lejeune, Laurent Robriquet, Sophie Six, Caroline Loïez, Frédéric Wallet

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Emerging infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Strategies for Survival ofInternational journal of molecular sciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2023
    Review
  15. Biogenic silver nanoparticles eradicate ofFrontiers in microbiology · 2023
    Article
  16. A Review of Antibiotic Efficacy in COVID-19 Control.Journal of immunology research · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Claire Duployez
Rémi Le Guern
Claire Tinez
Anne-Laure Lejeune
Laurent Robriquet
Sophie Six
Caroline Loïez
Frédéric Wallet
Centre Hospitalier Universitaire de Lille · FRInserm · FRCenter for Infection and Immunity of Lille · FRInstitut de Biologie de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing pneumonia induced by Panton-Valentine leukocidin-secreting Staphylococcus aureus is a rare but life-threatening infection that has been described in patients after they had influenza. We report a fatal case of this superinfection in a young adult who had coronavirus disease.

Indexed as

AdultAnti-Bacterial AgentsBacterial ToxinsBetacoronavirusCefotaximeClindamycinClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingExotoxinsFatal OutcomeHumansLeukocidinsLinezolidMaleAnti-Bacterial AgentsBacterial ToxinsCefotaximeClindamycinExotoxinsLeukocidinsLinezolidMetronidazolePanton-Valentine leukocidinSpiramycinbacteriacoronavirus diseaseCOVID-19necrotizing pneumoniaPanton-Valentine leukocidinSARS-CoV-2severe acute respiratory syndrome coronavirus 2Staphylococcus aureus

Identifiers

PMID32298228
PMCPMC7392470
OpenAlexW3016395804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.